Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study

BACKGROUND: COVID-19 vaccination is crucial in combating the COVID-19 pandemic. Messenger RNA COVID-19 vaccines were initially authorized as a 2-dose primary series and have been widely used in the United States; completing the 2-dose primary series offers protection against infection, severe illnes...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Stanley, Hong, Vennis, Sy, Lina S, Bruxvoort, Katia J, Lewin, Bruno, Han, Bing, Holmquist, Kimberly J, Qian, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563864/
https://www.ncbi.nlm.nih.gov/pubmed/37792452
http://dx.doi.org/10.2196/46318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563864/
https://www.ncbi.nlm.nih.gov/pubmed/37792452
http://dx.doi.org/10.2196/46318

Ejemplares similares